ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,654Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1187

$673K Total Retail Price of All Prescriptions

Rank: 12 out of 1187

585 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oregon
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 585 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

17% of this provider’s 585 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 582 533 89 1 3
OMEPRAZOLE 545 471 86 2 4
LEVOTHYROXINE SODIUM 453 397 75 3 2
METOPROLOL SUCCINATE 402 391 65 4 18
AMLODIPINE BESYLATE 374 356 63 5 6
LISINOPRIL 316 311* 68 6 1
METFORMIN HCL 289 235 58 7 7
ATORVASTATIN CALCIUM 269 255 49 8 8
GABAPENTIN 247 222 47 9 12
FUROSEMIDE 240 207 45 10 9
HYDROCODONE-ACETAMINOPHEN 236 207 84 S3 11 5
CITALOPRAM HBR 227 208 36 12 20
WARFARIN SODIUM 187 187 35 13 13
POTASSIUM CHLORIDE 185 172 36 14 17
BYSTOLIC 158 140 24 15 99
METOPROLOL TARTRATE 149 126 33 16 15
ATENOLOL 142 137* 25 17 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 122 31 18 27
JANUVIA 128 81 15 19 113
HYDROCHLOROTHIAZIDE 122 98 23 20 10
PAROXETINE HCL 118 113* 19 21 52
TRAZODONE HCL 117 104 24 22 21
CRESTOR 115 99 24 23 55
CYMBALTA 112 84 15 24 45
RAMIPRIL 100 95* 15 25 160
ALLOPURINOL 99 81 20 26 30
SPIRIVA 98 93* 19 27 51
LOSARTAN POTASSIUM 93 93 15 28 14
ADVAIR DISKUS 92 79 19 29 38
PANTOPRAZOLE SODIUM 92 87* 18 29 41
QUETIAPINE FUMARATE 88 74 18 A 31 64
NAMENDA 88 <11 <11 31 70
BENICAR 84 79* 15 33 122
VENLAFAXINE HCL ER 84 59 15 33 72
DONEPEZIL HCL 81 76* 14 35 43
VALSARTAN-HYDROCHLOROTHIAZIDE 81 67 14 35 164
SERTRALINE HCL 75 43 15 37 23
PREDNISONE 75 70* 31 37 42
TAMSULOSIN HCL 74 69* 16 39 25
ESTRADIOL 71 54 11 R 40 61
CARVEDILOL 69 58 15 41 26
BENICAR HCT 68 <11 <11 42 192
OLANZAPINE 67 35 13 A 43 130
ALPRAZOLAM 66 61* 21 B 44 35
ESCITALOPRAM OXALATE 65 <11 <11 45 68
GLYBURIDE 63 63 12 R 46 107
LOSARTAN-HYDROCHLOROTHIAZIDE 62 <11 <11 47 57
DIGOX 62 57* 11 47 154
LORAZEPAM 60 55* 21 B 49 32
LANTUS SOLOSTAR 60 55* 15 49 76
DIOVAN 59 <11 <11 51 100
ZOLPIDEM TARTRATE 58 53* 21 52 24
MIRTAZAPINE 57 <11 <11 53 63
FAMOTIDINE* 56 <11 <11 54 83
LAMOTRIGINE 55 <11 <11 55 127
AMITRIPTYLINE HCL 54 39 11 R 56 47
CELEBREX 53 <11 <11 57 144
LANTUS 53 <11 <11 57 48
PROAIR HFA 53 39 20 57 29
FLUTICASONE PROPIONATE 51 39 20 60 34
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.